Tiotropium Bromide hydrate
CAS No. | 139404-48-1 | Cat. No. | BCP02924 |
Name | Tiotropium Bromide hydrate | ||
Synonyms | Spiriva; | ||
Formula | C19H22NO4S2.Br.xH2O | M. Wt | 490.43 |
Description | Tiotropium bromide is a novel potent and long-lasting muscarinic antagonist that has been developed for the treatment of chronic obstructive airways disease. Binding studies with [3H]tiotropium bromide in human lung have confirmed that this is a potent muscarinic antagonist with equal affinity for M1-, M2- and M3-receptors and is approximately 10-fold more potent than ipratropium bromide. In vitro tiotropium bromide has a potent inhibitory effect against choliergic nerve-induced contraction of guinea-pig and human airways, that has a slower onset than atropine or ipratropium bromide. tiotropium bromide dissociates slowly from M3-receptors (on airway smooth muscle) but rapidly from M2 autoreceptors (on cholinergic nerve terminals) . Tiotropium bromide is a quaternary ammonium derivative that binds to muscarinic receptors. However, although tiotropium binds with high affinity to muscarinic receptors of M1-, M2- and M3-subtypes, it dissociates very slowly from M1- and M3-receptors but mor | ||
Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
Targets | mAChR |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.